Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...
Long COVID, a debilitating condition following SARS-CoV-2 infection, continues to disable tens of millions of people globally, yet no approved treatments ...
With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
President Donald Trump's nominees to run the National Institutes of Health and the Food and Drug Administration are part of a group of scientists censored during the COVID-19 pandemic who are ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...
Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback